Omnicell, Inc.

NASDAQ:OMCL

Medical - Healthcare Information Services

Healthcare
$34.66 -1.49%

-$0.58 today

Market cap
$1.59B
Beta
0.96
P/E (TTM)
84.1
EPS (TTM)
$0.45
52W Low $26.85High $55.00

Volume 0.34M

Average 0.57M

OMCL Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Omnicell, Inc.NASDAQ: OMCL

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI remains negative

Q1 FY2026 Accumulated OCI was -$10.64M, compared with -$13.81M a year earlier.

Context

  • Accumulated OCI amounted to 0.5% of total assets at the end of Q1 FY2026, down 0.1 pp from a year earlier.
  • Accumulated OCI grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +22.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$10.64M-20.2% QoQ
Last fiscal yearDec 2025
-$8.85M+48.5% YoY
Year agoMar 2025
-$13.81M+22.9% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.9%——
1 year+48.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
(8.85M) USD
Year-over-year change
+48.5%

Accumulated OCI vs competitors

How OMCL compares with its peers on the latest reported figures

  • OMCL's Mar 2026 Accumulated OCI of -$10.64M is the 10th highest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of +22.9% is the 2nd highest of 8, against a peer median of -56.2%.
  • Accumulated OCI amounts to 0.5% of total assets for OMCL, versus a peer median of 0.0%.
OMCL Competitors Peer median
Accumulated OCI for OMCL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
UFPTUFP Technologies, Inc.Jun 2026$1.51M -56.2%—0.2%
PGNYProgyny, Inc.Jun 2026$245K +12.4%-0.2%0.0%
TXG10x Genomics, Inc.Sep 2026$197K +42.8%—0.0%
ASTHAstrana Health, Inc.Mar 2026$0 ——0.0%
OMDAOmada HealthMar 2026$0 ——0.0%
GDRXGoodRx Holdings, Inc.Mar 2026$0 ——0.0%
SDGRSchrödinger, Inc.Sep 2026-$131K -265.8%—0.0%
PHRPhreesia, Inc.Apr 2026-$571K -248.7%—0.1%
SSIISS Innovations International, Inc.Mar 2026-$2.67M -1645.2%—3.0%
OMCLOmnicell, Inc.Mar 2026-$10.64M +22.9%—0.5%
TDOCTeladoc Health, Inc.Mar 2026-$35.42M +4.9%—1.3%
Peer median (excluding OMCL) $0-56.2%-0.2%0.0%

Competitors are the stored peer set for OMCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents349.05M330.36M467.97M369.2M196.52M
Short-term Investments10.67M11.49M012.48M0
Net Receivables240.89M299.47M263.89M256.4M216.86M
Inventory119.92M147.55M110.1M88.66M100.91M
Other Current Assets31.01M64.17M51.36M61.48M132.08M
Total Current Assets780.7M881.81M927.57M815.49M680.07M
Property, Plant & Equipment (Net)119.69M132.01M133.59M138.3M144.48M
Goodwill738.9M734.27M735.81M734.73M737.95M
Intangible Assets374.61M323.67M277.83M246.7M170.11M
Long-term Investments18.39M32.92M54.8M52.74M60.74M
Tax Assets15.88M22.33M32.9M57.47M58.34M
Other Non-current Assets94.32M83.74M64.37M75.53M123.04M
Total Non-current Assets1.36B1.33B1.3B1.31B1.29B
Total Assets2.14B2.21B2.23B2.12B1.97B
Account Payables71.51M63.39M45.03M51.78M43.99M
Short-term Debt488.15M00174.32M0
Tax Payables3.77M9.64M2.19M11.44M0
Deferred Revenue152.11M187.21M132.29M201.98M283.48M
Other Current Liabilities71.13M73.46M126.02M60.31M57.17M
Total Current Liabilities876.16M428.45M367.79M595.68M476.61M
Long-term Debt0566.57M569.66M166.4M167.6M
Deferred Tax Liabilities51.71M2.1M1.62M1.11M683K
Deferred Revenue (Non-current)20.19M37.39M58.62M76.12M63.25M
Other Non-current Liabilities7.84M6.72M6.32M7.22M9.97M
Total Non-current Liabilities119.65M652.18M670.13M281.97M266.3M
Total Liabilities995.81M1.08B1.04B877.65M742.91M
Common Stock54K55K56K57K58K
Retained Earnings368.57M390.73M370.36M382.89M384.94M
Accumulated OCI(8.41M)(17.09M)(13.43M)(17.2M)(8.85M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.15B1.13B1.19B1.24B1.23B
Total Debt541.01M616.74M614.09M382.55M204.35M
Net Debt191.96M286.38M146.12M13.35M7.83M

Omnicell, Inc.

NASDAQ:OMCL

Intrinsic Alpha fair value

Locked

Current Price

$34.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.